| Title |
An immune-active tumor microenvironment favors clinical response to ipilimumab
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, December 2011
|
| DOI | 10.1007/s00262-011-1172-6 |
| Pubmed ID | |
| Authors |
Rui-Ru Ji, Scott D. Chasalow, Lisu Wang, Omid Hamid, Henrik Schmidt, John Cogswell, Suresh Alaparthy, David Berman, Maria Jure-Kunkel, Nathan O. Siemers, Jeffrey R. Jackson, Vafa Shahabi |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 489 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | <1% |
| Spain | 2 | <1% |
| Denmark | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Mexico | 1 | <1% |
| Russia | 1 | <1% |
| Unknown | 479 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 96 | 20% |
| Student > Ph. D. Student | 92 | 19% |
| Student > Master | 60 | 12% |
| Student > Bachelor | 49 | 10% |
| Other | 41 | 8% |
| Other | 71 | 15% |
| Unknown | 80 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 128 | 26% |
| Agricultural and Biological Sciences | 93 | 19% |
| Biochemistry, Genetics and Molecular Biology | 81 | 17% |
| Immunology and Microbiology | 46 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 3% |
| Other | 38 | 8% |
| Unknown | 90 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#1,550,525
of 23,299,593 outputs
Outputs from Cancer Immunology, Immunotherapy
#46
of 2,920 outputs
Outputs of similar age
#10,969
of 243,483 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#1
of 38 outputs
Altmetric has tracked 23,299,593 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,920 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,483 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.